Loading...
 
Back to the list
Mediterr J Rheumatol 2017;28(1):52-6
Article Links
Bronchus-associated lymphoid tissue lymphoma (BALT) in a patient with primary Sjögren’s syndrome
Evangelia N. Mole, Vasilios T. Papadakos, Charalampos I. Sfontouris
Authors Information
Department of Rheumatology, Evaggelismos General Hospital, Athens, Greece
Keywords: Sjögren’s syndrome, BALT lymphoma, R-CHOP, biopsy
References
  1. Zintzaras E, Voulgarelis M, Moutsopoulos H M. The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med 2005;165:2337-44.
  2. Tzioufas A G, Voulgarelis M. Update on Sjogren's syndrome autoimmune epithelitis: from classification to increased neoplasias. Best Pract Res Clin Rheumatol 2007;21:989-1010.
  3. Watanabe Y, Koyama S, Miwa C, Okuda S, Kanai Y, Tetsuka K, et al. Pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma in Sjogren's syndrome showing only the LIP pattern radiologically. Intern Med 2012;51:491-5.
  4. Pathak V, Resnick J M, Islam T. Bilateral pulmonary nodules and mediastinal lymphadenopathy in a patient with Sjogren's syndrome. WMJ 2014;113:32-4.
  5. Ramos-Casals M, Brito-Zeron P, Yague J, Akasbi M, Bautista R, Ruano M, et al. Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren's syndrome. Rheumatology (Oxford) 2005;44:89-94.
  6. Papiris S A, Kalomenidis I, Malagari K, Kapotsis G E, Harhalakis N, Manali E D, et al. Extranodal marginal zone B-cell lymphoma of the lung in Sjogren's syndrome patients: reappraisal of clinical, radiological, and pathology findings. Respir Med 2007;101:84-92.
  7. Voulgarelis M, Dafni U G, Isenberg D A, Moutsopoulos H M. Malignant lymphoma in primary Sjogren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjogren's Syndrome. Arthritis Rheum 1999;42:1765-72.
  8. Ioannidis J P, Vassiliou V A, Moutsopoulos H M. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjogren's syndrome. Arthritis Rheum 2002;46:741-7.
  9. Anaya J M, McGuff H S, Banks P M, Talal N. Clinicopathological factors relating malignant lymphoma with Sjogren's syndrome. Semin Arthritis Rheum 1996;25:337-46.
  10. Fragkioudaki S, Mavragani C P, Moutsopoulos H M. Predicting the risk for lymphoma development in Sjogren syndrome: An easy tool for clinical use. Medicine 2016;95:e3766.
  11. Egashira R, Kondo T, Hirai T, Kamochi N, Yakushiji M, Yamasaki F, et al. CT findings of thoracic manifestations of primary Sjogren syndrome: radiologic-pathologic correlation. Radiographics 2013;33:1933-49.
  12. Costa M B, Siqueira S A, Saldiva P H, Rabe K F, Mauad T. Histologic patterns of lung infiltration of B-cell, T-cell, and Hodgkin lymphomas. Am J Clin Pathol 2004;121:718-26.
  13. Oh S Y, Kim W S, Kim J S, Kim S J, Kwon H C, Lee D H, et al. Pulmonary marginal zone B-cell lymphoma of MALT type--what is a prognostic factor and which is the optimal treatment, operation, or chemotherapy?: Consortium for Improving Survival of Lymphoma (CISL) study. Ann Hematol 2010;89:563-8.